Within the scientific and clinical communities, homeopathy has been a part of the conversation around autism spectrum disorder (ASD) treatment options for years, but evidence supporting its use remains slim.
Compelling evidence has begun to emerge in support of modern dietary interventions for those who seek to alleviate IBD symptoms noninvasively, including the FODMAP diet and targeted nutraceutical interventions.
Clarification of the connection between autism and gut bacteria is helping scientists, clinicians, parents, and patients better understand the complexities of autism-related symptoms and their potential causes.
As the body of research highlighting potential health benefits of butyric acid grows, both researchers and health practitioners are recommending bioavailable butyric acid supplements for patients with a wide variety of health conditions.
As alternative medicine enters the mainstream and nutraceuticals gain popularity, specialized bioavailability pharmacology is becoming paramount to delivering optimal therapeutic benefits to patients .
For many years, alternative medicine remained outside mainstream medicine due to a paucity of scientifically validated evidence, but this is changing thanks to new developments in alternative medicine research and evolving perspectives among patients and clinicians.
Crohn’s disease is notoriously difficult to manage. Despite the fact that traditional pharmaceuticals and biologic therapies are available, for many sufferers, these options are insufficient for effectively reducing symptoms.
The use of antibiotics is all too common in modern medicine, with risks that are becoming increasingly evident. While they are literally life-saving in many instances, they may also lead to antibiotic-induced colitis in some patients.
A growing body of research into autism and gastrointestinal problems suggests that treatments targeting the gut microbiome may provide significant relief for distressing symptoms and improve quality of life for patients.
Nutraceutical complementary therapies for autism are experiencing broader mainstream acceptance in the clinical context, but evidence suggests that optimizing the benefits of these therapies depends on bioavailability.
In recent years, researchers have been increasingly recognizing the gut-brain axis as a potential target for intervention in a broad range of challenging medical conditions, including neurological, intestinal, and psychiatric disorders.